EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Advances in the Research of Hypoxia-Inducible Factor-1Alpha and Plasminogen Activator Inhibitor-1 in Vascular-Related Diseases

Xiao Xu, Xiao Hu Ge

Journal of Clinical Medicine Research · 2026-03 · 18 (3) · 157-167

DOI: 10.14740/jocmr6330 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine Research, 2026-03. Verfasst von Xiao Xu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Xinjiang Medical University Graduate School, Urumqi, Xinjiang Uygur Autonomous Region, Urumqi 831500, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypoxia-inducible factor-1α (HIF-1α) and plasminogen activator inhibitor-1 (PAI-1) play crucial roles in vascular homeostasis and pathological remodeling. Their intertwined regulatory network represents a focal point in vascular disease research. Under physiological conditions, HIF-1α and PAI-1 act coordinately to maintain vascular adaptability and repair capacity. However, under pathological conditions such as hypoxia or metabolic dysregulation, their aberrant activation constitutes a significant driver of vascular pathologies, including thrombosis, fibrosis, and atherosclerosis. Consequently, targeting this regulatory network may offer novel therapeutic approaches for vascular diseases. Cellular exposure to stressors such as hypoxia or inflammation induces the expression of key regulatory factors including HIF-1α and PAI-1. As the principal transcription factor mediating hypoxic responses, HIF-1α activates downstream target genes such as vascular endothelial growth factor (VEGF) and glucose transporter 1 (GLUT1), thereby regulating angiogenesis, metabolic reprogramming, and inflammatory responses. PAI-1, a serine protease inhibitor, contributes critically to thrombosis, fibrosis, and endothelial dysfunction through inhibition of the fibrinolytic system and modulation of extracellular matrix (ECM) degradation.

Schlagwörter

Stichwörter der Autor:innen

Fibrinolysis systemHIF-1αHypoxia signalPAI-1Targeted therapyVascular remodeling

Autor:innen und Institutionen

  • Xinjiang Medical University Graduate School, Urumqi, Xinjiang Uygur Autonomous Region, Urumqi 831500, China.
  • Department of Vascular Surgery, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang Uygur Autonomous Region, Urumqi 831500, China.

Zitieren

APA

Xu, X., & Ge, X. H. (2026). Advances in the Research of Hypoxia-Inducible Factor-1Alpha and Plasminogen Activator Inhibitor-1 in Vascular-Related Diseases. Journal of Clinical Medicine Research, 18(3), 157-167. https://doi.org/10.14740/jocmr6330

Vancouver

Xu X, Ge XH. Advances in the Research of Hypoxia-Inducible Factor-1Alpha and Plasminogen Activator Inhibitor-1 in Vascular-Related Diseases. Journal of Clinical Medicine Research. 2026;18(3):157-167. doi:10.14740/jocmr6330

BibTeX
@article{Xu2026,
  author = {Xu, Xiao and Ge, Xiao Hu},
  title = {Advances in the Research of Hypoxia-Inducible Factor-1Alpha and Plasminogen Activator Inhibitor-1 in Vascular-Related Diseases},
  journal = {Journal of Clinical Medicine Research},
  year = {2026},
  volume = {18},
  number = {3},
  pages = {157--167},
  doi = {10.14740/jocmr6330}
}
Kostenlos starten →